Families of noncoding RNA
Subfamilies of RNA are being increasingly recognized as having important roles in gene regulation. Some of these RNAs have similar lengths and splicing structures to mRNA, but do not encode proteins. Already thousands of these noncoding RNAs, which include long intergenic noncoding RNAs (lincRNAs), long noncoding RNAs (lncRNAs), and small nucleolar RNAs (snoRNAs), have been discovered, but relatively few have been functionally characterized.
Most noncoding RNAs are localized to the nucleus, limiting the use of RNAi for loss-of-function studies due to the low prevalence of the requisite enzymes in the nucleus . However, RNase H, which is present in the nucleus, can be engaged to mediate RNA degradation, enabling the use of chemically modified antisense DNA oligonucleotides to downregulate targeted nuclear noncoding RNAs.
Using antisense oligonucleotides to regulate noncoding RNAs
Antisense oligonucleotides (ASOs) are short, synthetic 14–22 nt oligonucleotides that localize to the nucleus. They include phosphorothioate (PS) linkages that confer nuclease resistance, thus enhancing intracellular stability. A PS bond is created by replacing one of the non-bridging oxygen atoms in the phosphate backbone of the oligo with a sulfur atom (Figure 1). Inclusion of PS bonds increases oligonucleotide half-life in human serum by up to 10 hours compared to approximately 1 hour for an unmodified oligonucleotide with the same nucleotide sequence . However, the introduction of PS bonds lowers the binding affinity of the oligonucleotides and can cause cytotoxicity.
2’-O-alkyl groups increase antisense effectiveness
Further modifications to PS-modified oligos help to increase their binding affinity and reduce toxicity. A commonly used modification is introduction of 2’-O-methyl (2’OMe; Figure 2) RNA to create a “gapmer” ASO, a chimeric oligo comprising a DNA sequence with flanking 2’OMe nucleotides that help offset the reduction in binding affinity from the PS linkages. ASOs containing these 2’OMe modifications display enhanced nuclease resistance in addition to lower toxicity and increased hybridization affinities.
Enabling RNase H cleavage in antisense applications
RNase H, an endogenous enzyme found in all cells, specifically cleaves RNA linkages in a double-stranded RNA:DNA heteroduplex [3,4,5], making RNase H cleavage of the target the most effective mechanism for antisense activity. 2'OMe nucleotides are not recognized by RNase H; therefore, ASOs designed for RNase H–mediated degradation cannot be comprised entirely of 2'OMe nucleotides. For RNase H–mediated antisense activation, the gapmer ASO, comprising a central block of 10 DNA nucleotides flanked by blocks of 4–5 Tm-enhancing 2'OMe nucleotides  (Figure 3), is the favored design, allowing RNase H to cleave target RNA bound to the DNA core of the gapmer ASO.
Designing effective antisense oligonucleotides
There are currently no predictive algorithms for ASO design as the inability to predict target accessibility makes it difficult to develop such algorithms. Targets could be inaccessible due to protein binding or inherent RNA secondary structure. IDT recommends empirical testing by performing an initial screen using 5–10 PS-modified, standard, desalted DNA oligos to establish target accessibility. Once an accessible site is located, the PS-modified DNA ASO can be substituted with a 2’OMe gapmer ASO to reduce toxicity and, importantly, increase Tm, which correlates with increased ASO potency.
RNase H–dependent antisense silencing using gapmer ASOs is a powerful tool for specific modulation of nuclear noncoding RNAs. The technique also holds promise as a therapeutic tool for correcting RNA gain-of-function effects in RNA-dominant diseases . For help with designing your antisense experiments, contact our application support scientists at email@example.com.